haloperidol and ngd 94-1

haloperidol has been researched along with ngd 94-1 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, X; Donovan, H; He, XS; Hoffman, DC; Hutchison, A; Jones-Hertzog, DK; Meade, R; Thurkauf, A; Wasley, JW; Woodruff, KH; Yuan, J1
Hopkins, CR; Lindsley, CW1
Elsworth, JD; Jentsch, JD; Redmond, DE; Roth, RH; Taylor, JR; Youngren, KD1

Reviews

1 review(s) available for haloperidol and ngd 94-1

ArticleYear
Return of D
    Journal of medicinal chemistry, 2017, 09-14, Volume: 60, Issue:17

    Topics: Animals; Drug Discovery; Humans; Ligands; Molecular Targeted Therapy; Neoplasms; Parkinson Disease; Receptors, Dopamine D4; Small Molecule Libraries; Substance-Related Disorders

2017

Other Studies

2 other study(ies) available for haloperidol and ngd 94-1

ArticleYear
2-Phenyl-4(5)-[[4-(pyrimidin-2-yl)piperazin-1-yl]methyl]imidazole. A highly selective antagonist at cloned human D4 receptors.
    Journal of medicinal chemistry, 1997, Jan-03, Volume: 40, Issue:1

    Topics: Antipsychotic Agents; Clozapine; Dopamine D2 Receptor Antagonists; Humans; Receptors, Dopamine D4

1997
Dopamine D4 receptor antagonist reversal of subchronic phencyclidine-induced object retrieval/detour deficits in monkeys.
    Psychopharmacology, 1999, Volume: 142, Issue:1

    Topics: Animals; Chlorocebus aethiops; Cognition Disorders; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Female; Hallucinogens; Haloperidol; Imidazoles; Male; Phencyclidine; Prefrontal Cortex; Pyrimidines; Receptors, Dopamine D4

1999
chemdatabank.com